Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices 
Oil Prices Rebound as Trump Orders Blockade of Sanctioned Venezuelan Tankers 
Asian Stocks Edge Higher as Tech Recovers, U.S. Economic Uncertainty Caps Gains 
Silver Prices Hit Record High as Safe-Haven Demand Surges Amid U.S. Economic Uncertainty 
Asian Markets Rebound as Tech Rally Lifts Wall Street, Investors Brace for BOJ Rate Hike 
Japan Inflation Holds Firm in November as BOJ Nears Key Rate Hike Decision 
BoE Set to Cut Rates as UK Inflation Slows, but Further Easing Likely Limited 
Gold and Silver Prices Dip as Markets Await Key U.S. Economic Data 
Chinese Robotaxi Stocks Rally as Tesla Boosts Autonomous Driving Optimism 
BOJ Poised for Historic Rate Hike as Japan Signals Shift Toward Monetary Normalization 
Canada Signals Delay in US Tariff Deal as Talks Shift to USMCA Review 
U.S. Dollar Steadies Near October Lows as Rate Cut Expectations Keep Markets on Edge 
RBA Unlikely to Cut Interest Rates in 2026 as Inflation Pressures Persist, Says Westpac 
U.S. Stock Futures Slip After CPI-Fueled Rally as Markets Weigh Economic Uncertainty 
Yen Near Lows as Markets Await Bank of Japan Rate Decision, Euro Slips After ECB Signals Caution 
Gold and Silver Surge as Safe Haven Demand Rises on U.S. Economic Uncertainty 
Dollar Holds Firm Ahead of Global Central Bank Decisions as Yen, Sterling and Euro React 
Ireland’s economic growth is expected to slow in 2024 as global risks mount, posing a significant challenge to its multinational-driven economy, the country's central bank warned. The bank revised its forecast for modified domestic demand (MDD) to 2.7% from 3.1%, citing uncertainty affecting consumption, exports, and investment.
A key concern is Ireland’s heavy reliance on U.S. multinational corporations, which contribute significantly to employment, tax revenue, and exports. U.S. President Donald Trump’s recent criticism of Ireland’s trade surplus and low corporate tax rate has intensified fears of economic disruption. His proposed 25% tariff on pharmaceutical imports and potential tax policy shifts could heavily impact Ireland’s economy, especially if companies are incentivized to relocate production and profits back to the U.S.
The foreign multinational sector, predominantly U.S.-owned, employs 11% of Ireland’s workforce and accounts for a major share of corporate tax revenue, which makes up 26% of total tax collected. The central bank warned that policy changes in Washington could cause a fiscal shock by significantly reducing corporate tax inflows.
Despite the risks, Ireland’s pharmaceutical exports to the U.S. have surged, growing by 68% year-on-year in January, driven partly by increased demand for weight-loss drugs. While some of this may be linked to stockpiling ahead of potential tariffs, absent any trade barriers, it could provide an unexpected boost to exports.
The central bank emphasized Ireland’s vulnerability to decisions made by a few multinational firms but noted possible upsides if export trends continue. As uncertainty looms, policymakers must navigate these risks to safeguard economic stability.
